Tioga Cardiovascular Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$22.9M
- Investors
-
7
Tioga Cardiovascular General Information
Description
Manufacturer of medical equipment technology intended to provide valve replacement devices for mitral applications. The company's technology is procedurally simpler and uses a less invasive, transcatheter approach, and is focused on providing a new, elegant, valve replacement solution for mitral applications, enabling doctors to perform heart surgeries effectively and successfully.
Contact Information
Website
www.tiogacardiovascular.comCorporate Office
- 130 Knowles Drive
- Suite A
- Los Gatos, CA 95032
- United States
Corporate Office
- 130 Knowles Drive
- Suite A
- Los Gatos, CA 95032
- United States
Tioga Cardiovascular Timeline
Tioga Cardiovascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series D) | 16-Sep-2025 | $22.9M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series C) | 07-Feb-2023 | Completed | Pre-Clinical Trials | |||
| 4. Later Stage VC (Series B) | 25-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 3. Later Stage VC (Series A2) | 12-Apr-2019 | Completed | Product In Beta Test | |||
| 2. Early Stage VC (Series A1) | 22-Mar-2016 | $570K | $1.97M | Completed | Product In Beta Test | |
| 1. Early Stage VC (Series A) | 08-Jun-2012 | $1.4M | $1.4M | Completed | Startup |
Tioga Cardiovascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D-1 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | 3,132,492 | $0.000100 | 8% | $0.58 | $0.58 | 1x | $0.58 | 1.71% |
| Series A | 2,750,000 | $0.000100 | 8% | $0.29 | $0.29 | 1x | $0.29 | 1.5% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Tioga Cardiovascular Comparisons
Industry
Financing
Details
Tioga Cardiovascular Competitors (5)
One of Tioga Cardiovascular’s 5 competitors is Cardiovalve, a Formerly VC-backed company based in Or Yehuda, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cardiovalve | Formerly VC-backed | Or Yehuda, Israel | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| HighLife | Venture Capital-Backed | Paris, France | ||||
| Edwards Lifesciences | Corporation | Irvine, CA | ||||
| Abbott | Corporation | Abbot Park, IL |
Tioga Cardiovascular Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tioga Cardiovascular Patents
Tioga Cardiovascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4746826-A2 | Prosthetic cardiac valve device, systems, and methods | Pending | 21-Jul-2023 | ||
| EP-4676396-A2 | Prosthetic cardiac valve device, systems, and methods | Pending | 07-Mar-2023 | ||
| EP-4608333-A2 | Prosthetic heart valve delivery system and method | Pending | 26-Oct-2022 | ||
| EP-4608333-A4 | Prosthetic heart valve delivery system and method | Pending | 26-Oct-2022 | ||
| US-20260174554-A1 | Prosthetic heart valve delivery system and method | Pending | 26-Oct-2022 | A61F2/2436 |
Tioga Cardiovascular Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tioga Cardiovascular Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| PA MedTech VC Fund | Corporate Venture Capital | Minority | ||
| Techlink Ventures | Venture Capital | Minority | ||
| Cormorant Asset Management | PE/Buyout | Minority | ||
| Shifamed | Accelerator/Incubator | Minority | ||
| AMED Ventures | Venture Capital | Minority |
Tioga Cardiovascular FAQs
-
When was Tioga Cardiovascular founded?
Tioga Cardiovascular was founded in 2012.
-
Where is Tioga Cardiovascular headquartered?
Tioga Cardiovascular is headquartered in Los Gatos, CA.
-
What is the size of Tioga Cardiovascular?
Tioga Cardiovascular has 12 total employees.
-
What industry is Tioga Cardiovascular in?
Tioga Cardiovascular’s primary industry is Surgical Devices.
-
Is Tioga Cardiovascular a private or public company?
Tioga Cardiovascular is a Private company.
-
What is the current valuation of Tioga Cardiovascular?
The current valuation of Tioga Cardiovascular is .
-
What is Tioga Cardiovascular’s current revenue?
The current revenue for Tioga Cardiovascular is .
-
How much funding has Tioga Cardiovascular raised over time?
Tioga Cardiovascular has raised $105M.
-
Who are Tioga Cardiovascular’s investors?
PA MedTech VC Fund, Techlink Ventures, Cormorant Asset Management, Shifamed, and AMED Ventures are 5 of 7 investors who have invested in Tioga Cardiovascular.
-
Who are Tioga Cardiovascular’s competitors?
Cardiovalve, Medtronic, HighLife, Edwards Lifesciences, and Abbott are competitors of Tioga Cardiovascular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
